Literature DB >> 25100368

A sporadic case of pseudohypoparathyroidism type 1 and idiopathic primary adrenal insufficiency associated with a novel mutation in the GNAS1 gene.

Santosh K Chaubey1, Kunwarjit S Sangla2.   

Abstract

OBJECTIVE: We report an atypical association of primary adrenal insufficiency and pseudohypoparathyroidism (PHP) and a novel GNAS1 gene mutation in a Caucasian female who initially presented with adrenal crisis.
METHODS: A case report and literature review.
RESULTS: A 37-year-old female presented with shock at 11 years of age, and investigations revealed primary adrenal insufficiency and pseudohypoparathyroidism (PHP). She had typical features of Albright hereditary osteodystrophy (AHO) and evidence of thyroid-stimulating hormone (TSH), growth-hormone-releasing hormone (GHRH), and gonadotrophin resistance fitting with the diagnosis of PHP type 1a/1c. She did not have a family history of any autoimmune disease or PHP. Her mother was phenotypically normal. Genomic DNA sequencing of those GNAS exons and adjacent intronic regions that encode the stimulatory guanine nucleotide-binding protein Gsα revealed a novel heterozygous mutation in exon 11, c.857-858delCT.
CONCLUSION: The association of primary adrenal insufficiency and PHP has not been reported in literature and may prove an area for further research. The novel mutation in this case adds to the spectrum of mutations associated with these disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25100368     DOI: 10.4158/EP14020.CR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  5 in total

1.  Identification of a novel GNAS mutation in a case of pseudohypoparathyroidism type 1A with normocalcemia.

Authors:  Xiao-Dan Long; Jing Xiong; Zhao-Hui Mo; Chang-Sheng Dong; Ping Jin
Journal:  BMC Med Genet       Date:  2018-07-30       Impact factor: 2.103

2.  GNAS mutation is an unusual cause of primary adrenal insufficiency: a case report.

Authors:  Yajie Tong; Dongmei Yue; Ying Xin; Dan Zhang
Journal:  BMC Pediatr       Date:  2022-08-04       Impact factor: 2.567

3.  (Epi)genotype-Phenotype Analysis in 69 Japanese Patients With Pseudohypoparathyroidism Type I.

Authors:  Shinichiro Sano; Akie Nakamura; Keiko Matsubara; Keisuke Nagasaki; Maki Fukami; Masayo Kagami; Tsutomu Ogata
Journal:  J Endocr Soc       Date:  2017-11-21

Review 4.  Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; Alessia Usardi; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Kathleen Freson; Aurora García Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Marie-Laure Kottler; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Masanori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebecca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

5.  Hypercalcitoninaemia in pseudohypo-parathyroidism type 1A and type 1B.

Authors:  Maria P Yavropoulou; Efstathios Chronopoulos; George Trovas; Emmanouil Avramidis; Francesca Marta Elli; Giovanna Mantovani; Pantelis Zebekakis; John G Yovos
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2019-01-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.